IDH2 and acute myeloid leukemia: Moreover, this compound reduced 2-HG levels, induced differentiation of primary IDH2-mutated AML blasts ex vivo and improved the survival of mice bearing an aggressive xenograft established from an AML patient harboring IDH2R140Q mutation [100].